TUDCA-treated chronic kidney disease-derived hMSCs improve therapeuticefficacy in ischemic disease via PrPC

Enhancement of Functionality and Therapeutic Efficacy of Cell-Based Therapy Using Mesenchymal Stem Cells for Cardiovascular Disease

TUDCA-Treated Mesenchymal Stem Cells Protect against ER Stress in the Hippocampus of a Murine Chronic Kidney Disease Model.

Melatonin protects chronic kidney disease mesenchymal stem cells against senescence via PrPC dependent enhancement of the mitochondrial function.

Melatonin protects mesenchymal stem cells from autophagymediateddeath under ischaemic ER­stress conditions byincreasing prion protein expression

The Roles of Autophagy in Cancer

Melatonin and 5-fluorouracil co-suppress colon cancer stem cells by regulating cellular prion protein-Oct4 axis.

Administration of Cripto in GRP78 overexpressed human MSCsenhances stem cell viability and angiogenesis during humanMSC transplantation therapy

Pioglitazone Protects Mesenchymal Stem Cells against P-Cresol-Induced Mitochondrial Dysfunction via Up-Regulation of PINK-1

Combination of MSC spheroids wrapped within autologous composite sheetdually protects against immune rejection and enhances stem celltransplantation efficacy